Search

Author/Creator Wutte, A.

1. A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes. Issue 3 (22nd October 2012)

Authors:
Korsatko, S.; Glettler, K.; Olsen, K. J.; Wutte, A.; Bock, G.; Koehler, G.; Mader, J. K.; Semlitsch, B.; Pieber, T. R.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 15:Issue 3(2013:Mar.)
Page Start:
241
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bioavailability of insulin detemir and human insulin at the level of peripheral interstitial fluid in humans, assessed by open‐flow microperfusion. Issue 12 (9th October 2015)

Authors:
Bodenlenz, M.; Ellmerer, M.; Schaupp, L.; Jacobsen, L. V.; Plank, J.; Brunner, G. A.; Wutte, A.; Aigner, B.; Mautner, S. I.; Pieber, T. R.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 17:Issue 12(2015:Dec.)
Page Start:
1166
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pharmacodynamics of the long‐acting insulin analogues detemir and glargine following single‐doses and under steady‐state conditions in patients with type 1 diabetes. Issue 1 (19th August 2013)

Authors:
Koehler, G.; Treiber, G.; Wutte, A.; Korsatko, S.; Mader, J. K.; Semlitsch, B.; Pieber, T. R.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 16:Issue 1(2014:Jan.)
Page Start:
57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗